4.5 Article

Insight into the structural flexibility and function of Mycobacterium tuberculosis isocitrate lyase

Journal

BIOCHIMIE
Volume 110, Issue -, Pages 73-80

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biochi.2014.12.016

Keywords

Isocitrate lyase; Structure; Activity; Drug target; Kinetics

Funding

  1. CSIR-YSA [YSA0001]
  2. CSIR-GENESIS [BSC0121]
  3. CSIR
  4. DBT, New Delhi

Ask authors/readers for more resources

Isocitrate lyase (ICL), is a key enzyme of the glyoxylate shunt crucial for the survival of Mycobacterium tuberculosis (Mtb) in macrophages during persistent infection. MtbICL catalyses the first step of this carbon anaplerosis cycle and is considered as a potential anti-tubercular drug target. The MtbICL is a tetramer with 222 symmetry, and each subunit of the enzymeis composed of 14 alpha-helices and 14 beta-strands. We studied the conformational flexibility of the enzyme to get a deeper insight into its stability and function. Our studies show that the mutation of His180, close to the MtbICL signature sequence (K(193)KCGH(197)) completely abolishes the oligomeric conformation and function of the enzyme. Molecular dynamics studies suggest that the loss of interaction between His180 and Tyr89 most likely alters the orientation of Tyr89 side chain, thereby causing the movement of helices alpha 6, alpha 12, alpha 13 and alpha 14 in the vicinity and affecting the tetrameric assembly. We further show that the oligomerization of MtbICL is primarily mediated by the inter subunit interactions, and strengthened by the helix swapping of alpha 12-alpha 13 between adjacent subunits. Furthermore, the enzyme activity is influenced by the interactions between the residues of lid region (P(411)NSSTTALTGSTEEGQFH(428)) and the loop region (T(391)KHQREV(397)). Mutation of glutamates of the lid region to non homologous residues (E423A or E424A) or basic residues (E423K or E424K) inactivates the enzyme, whereas the activity is not much compromised in case of homologous mutations (E423D or E424D). (C) 2015 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available